PeakO2 (mushroom blend): Research, Dosing, and Where to Buy in 2026
A research-first profile for PeakO2 (mushroom blend) (PeakO2, Pico2), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
PeakO2 (mushroom blend) is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for PeakO2 (mushroom blend), each linked to its source.
- Also indexed as PeakO2, Pico2.
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is PeakO2 (mushroom blend)?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
PeakO2 (mushroom blend) Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| S1 | Does Cialis Decrease Your Workout Performance? Enhancing EPO for... | 00:08:46 | 2,000 mg or 4,000 mg pre-workout; host takes 4,000 mg mixed into shake alongside Gorilla Mode Nitric | anecdotal |
Where to Buy PeakO2 (mushroom blend) in 2026
No tracked vendor recommendations for PeakO2 (mushroom blend) yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about PeakO2 (mushroom blend). Each line links to the original source.
- "Supplementation periods were followed by a 2.25 h cycling bout at close to 70%VO2max." · Nieman D et al, 2024 PubMed
- "Butyrate proportionally made up 53.1% of the total SCFA upon feeding the high-dose mushroom blend, compared to 27% on the control medium." · Verhoeven J et al, 2021 PubMed
PeakO2 (mushroom blend) Research Findings in Numbers
Quantitative results quoted verbatim from the indexed peer-reviewed studies and attributed clinical protocols below.
- 2,000 mg or 4,000 mg pre-workout S1
- host takes 4,000 mg mixed into shake alongside Gorilla Mode Nitric S1
- HAM-A: p = 0.002) and 12 weeks (STAI-S: p = 0.011 PMID 41540766
- Depression (BDI) scores significantly decreased at 6 weeks (p < PMID 41540766
- 0.001) and 12 weeks (p = 0.008). PMID 41540766
- Restake supplementation led to reductions in sleep quality scores (PSQI) at 6 weeks (p = 0.005) and 12 weeks (p < PMID 41540766
Research and Studies
8 PubMed-indexed papers reference PeakO2 (mushroom blend). Top 8 shown.
Legal Status
PeakO2 (mushroom blend) is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-16.
Frequently Asked Questions
Is PeakO2 (mushroom blend) FDA-approved?
PeakO2 (mushroom blend) is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for PeakO2 (mushroom blend)?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on PeakO2 (mushroom blend)?
8 PubMed-indexed paper(s) reference PeakO2 (mushroom blend) in our current research feed. See the Research and Studies section above for citations.